Abstract
Background
Vaccine hesitancy poses a substantial challenge to the field of public health. There are various factors that influence the willingness of parents to vaccinate their children. Addressing the factors contributing to vaccine hesitancy within the community has the potential to facilitate the development of more effective approaches for global vaccination initiatives. This study aims to assess parents' perspectives regarding the immunization of children aged five to 12 against COVID-19, including their experiences with adverse effects, as well as the factors that influence their hesitancy or acceptance of the vaccine in the Eastern Province of Saudi Arabia.
Methods
A web-based, cross-sectional study utilized an independently administered online questionnaire. The validated questionnaire was distributed to study participants through social networking platforms in order to recruit individuals from various locations in the eastern region of Saudi Arabia, such as Dammam, Al-Hassa, Al-Jubail, Ras Tanura, Dhahran, Al-Khobar, and Al-Qatif.
Results
The study encompassed a total of 399 participants. The most commonly reported adverse effects among the first and second children were pain at the injection site (1st child: 267 (66.70%), second child: 263 (66.20%)) and fever (1st child: 171 (43.10%), second child: 187 (47.50%)). A significant proportion of the participants, specifically 139 individuals (35%), expressed apprehension regarding immunization. This concern stemmed from various factors, including the fear of experiencing adverse effects, skepticism regarding the vaccine's efficacy, and exposure to potentially harmful information about the vaccine. Ninety-nine participants, accounting for 25% of the sample, indicated their agreement with the safety of COVID-19. Additionally, 104 participants, constituting 26% of the sample, held the belief that receiving vaccination aids in the prevention of severe illnesses caused by COVID-19. Notably, the most prevalent reason for vaccine hesitancy among participants was the fear of experiencing adverse effects. A total of 132 individuals, accounting for 33% of the participants, identified healthcare providers, including physicians and scientists, as reliable and trustworthy sources of vaccine information. A statistically significant correlation was observed between the demographic variables of the participants and their acceptance of the vaccine.
Conclusion
The study observed an acceptable vaccination rate among children aged five to 12 for the COVID-19 vaccine. Based on the investigation results, the primary apprehension expressed by parents regarding the immunization of their offspring pertained to the potential negative consequences associated with the vaccine. Nonetheless, it was observed that adverse effects were reported in less than fifty percent of vaccinated children. Addressing the concerns pertaining to the COVID-19 vaccination can enhance global participation in the immunization program aimed at mitigating future pandemics.
Keywords: sar- cov-2, covid-19 vaccine, parents’ attitude, vaccine side effects, covid 19
Introduction
The World Health Organization (WHO) labeled the coronavirus disease (COVID-19) outbreak a pandemic in March 2020. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus now causes COVID-19, an infectious disease that affects people of all ages and causes respiratory illness [1].
Decades of research and evolutionary advances in immunology, vaccinology, and adjuvant biology have resulted in the quick development and clinical testing of viable vaccines to prevent the SARS-CoV-2 pandemic. The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended BNT162b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine for persons 12 -15 years of age (this report refers to them as adolescents) on May 12, 2021, and for children aged five to 11 on the second of November 2021-2 [2-4]. In clinical trials with children and adolescents, the vaccine's effectiveness was better than 90% [5].
As with other more common vaccines, side effects are inevitable and may be unpredicted [6]. According to a survey carried out in the United States on the side effects of Pfizer-BioNTech COVID-19 vaccination that was given to children aged five to 11 years, 86.2% of all study participants experienced at least one local reaction at the site of injection, and 66.6% experienced at least one systemic reaction of mild to moderate severity [6]. Fatigue, headaches, chills, and new or worsening muscle pain were the most prevalent complaints [6]. The findings are consistent with the safety findings from the Pfizer-BioNTech COVID-19 vaccine prior approval trials, which were delivered to five to 11-year-old children [3].
Vaccinations for children under the age of 18 are frequently decided by their parents [7]. According to the findings of a web-based survey developed by the study's researchers in partnership with vaccine specialists from the Department of Public Health in England, 48% of parents or guardians would favor COVID-19 vaccine for their children under the age of 18 [7]. According to a Chinese study, parental approval of COVID-19 vaccination was much lower among physicians and nurses (44.5%) than among factory workers (72.6%) [8]. One research conducted in Saudi Arabia on the adverse effects of the COVID-19 Pfizer-BioNTech vaccination in children aged 12 to 18 years found that the most prevalent side effect was soreness or redness at the injection site [9].
Another study that was carried out in Saudi Arabia to examine the prevalence and associated causes of vaccination hesitancy in children during the COVID-19 era found that most mothers firmly agreed with the need for vaccination, with the main reason being concerns about side effects [10].
Concerningly, parental vaccine reluctance in the Kingdom of Saudi Arabia is likely to impact their children's immunization status [11]. In a research done in Saudi Arabia to pinpoint what influences parental acceptance and rejection, showed that immunization is the best strategy to prevent COVID-19 infection in themselves and their families and to stop the disease from spreading among the general population [12]. Furthermore, parents disclosed that they refused to vaccinate both themselves and their children because of the efficiency (18.7%) and adverse effects (22.9%) of the COVID-19 vaccine [11,12]. Additionally, some research shows a connection between participants' sociodemographic details and their perceptions of the effectiveness of the vaccine during the pandemic [11]. A study done in various Eastern Mediterranean Region (EMR) countries to assess the link between parents' socio-demographic variables and the status of COVID-19 vaccination of their children revealed that parents' age, education level, occupation, prior COVID-19 infection, and vaccination status all had a significant influence on their children's immunization rates [13]. Interestingly, parents who work or study in the health field are less likely to vaccinate their children than parents who work in other fields [13].
Most studies performed in Saudi Arabia focused on parents’ willingness and intentions regarding getting their child immunized against COVID-19 to begin with [14]. Our current study aims to investigate the COVID-19 vaccine's common side effects in children aged five to 12, assess parental attitudes, assess determinants of parental hesitancy, and determine the association between demographic characteristics and vaccination hesitancy in Saudi Arabia's eastern province. To the best of our knowledge, this study is the first in the literature to point out the determinants of parental hesitancy toward vaccination among those who have already received the vaccine in the region.
Materials and methods
Study design
A cross-sectional study was performed on children between the ages of five and 12 utilizing a self-administered online questionnaire for reporting adverse effects of the COVID-19 vaccine and parental acceptance towards immunization of children at this age against COVID-19. The study was conducted in Eastern province regions of Saudi Arabia including Dammam, Al-Hassa, Al-Jubail, Ras Tanura, Dhahran, Al-Khobar, and Al-Qatif during the period 2022 to 2023.
Study population and sample size
The study was successfully carried out in Saudi Arabia's Eastern Province, with a sample size of 384 participants. The sample size of parents of children between five to 12 years old is 384, which was obtained using the Richard Geiger equation, with a margin of error of 5%, a confidence of 95%, and a response distribution of 50% for the total children's population aged five to 12 (taken from the National Demographic Statistics Year 2016 participants) [15]. The information was collected randomly using an electronic questionnaire. After giving informed consent, participants filled out the questionnaire on Google Forms to be involved in the study.
Selection criteria
The study encompassed parents residing in the Eastern province with children aged five to 12 years, regardless of their COVID-19 vaccination status. The study excluded parents residing outside of the Eastern province or whose children were less than five or older than 12 years of age.
Data collection
The primary method of data collection was survey-based and the sampling technique used was simple random. The survey was developed in Arabic using Google Forms, and the link was shared across social media platforms as well as through quick response (QR) code in various community gathering places in the Eastern Province regions of Saudi Arabia, such as shopping, and family parks from 2022 to 2023. The questionnaire was created following an extensive literature search that included PubMed, Medline, Google Scholar, and other databases [9,16], with the goal of identifying potential and frequent short-term adverse effects of the COVID-19 vaccine and discouraging parental approval or denial of children's COVID-19 vaccination. The first section contained an introduction to the study's objectives, contact information for the study authors to allow communication among research authors and participants, and a consent part where participants agreed to participate in the research. The second section gathered general data regarding the participants in the research (parents of children), such as gender, age, academic degree, marital status, and number of children. The third section gathered general data regarding the children, including sex, age, and long-term conditions, whether the child has been immunized against COVID-19 and the number of doses received, the adverse effects associated with the COVID-19 vaccination, and the timing the persistence of the adverse effects. The fourth and fifth sections were designed to collect information about the COVID-19 vaccine's adverse effects and parental attitudes toward COVID-19 and its vaccine (Appendix 1).
Validation and reliability testing of the questionnaire
A pilot investigation was carried out to determine the study's feasibility, reliability, and validity. The reliability of the constructs was tested using Cronbach’s alpha, and all the alpha values were above 0.7. Validity was determined subjectively using face validity (expert opinions) and objectively by discriminate validity using the Fronell-Larcker criterion, and the square roots of average variance extracted (AVE) for each construct were found to be higher than the correlation between the same construct and the other constructs, which is a sign of discriminate validity (all values of AVE were more than 0.5).
Ethical issues
The confidentiality of the patient and the privacy of their data are priorities. Nothing that could raise ethical concerns, such as the participants' identities, was used. The ethical approval was granted by King Faisal University's College of Medicine's ethical committee (KFU-REC-2022-NOV-ETHICS301).
Statistical analysis
The data were analyzed using SPSS (BM Corp. Released 2019. IBM SPSS Statistics for Windows, Version 26.0. Armonk, NY: IBM Corp). The Chi-square test was used to test the association. Frequencies were used to present categorical variables while mean and standard deviation were used to represent continuous variables. A p-value of less than 0.05 for a 95% confidence interval was considered significant.
Results
Our study included 399 participants in total. The majority of the informants (82% were mothers), and around 39% of the participants ages ranged between 31 and 40 years. Regarding the education level of participants, more than half (57% had a bachelor's degree), 52% were employed, and 22% worked in the educational field. The vast majority of the participants (94% were married), and the rest were either divorced or widowed. More than half of the participants (51.6%) earned less than 15 thousand Saudi Arabian Riyals (SAR) as their monthly income. Regarding the number of children among the participants, less than one quarter, (22% had three children). Moreover, 16.3% of respondents reported their children had chronic diseases, distributed as asthma (6.5%), DM (6.3%), 5.3% sickle cell anemia (5.3%), other diseases (3%), and leukemia (2%). Overall, about half of the participants (48.9% of their five to 12-year-old children) had received the vaccine against COVID-19. Of those who had vaccinated their children, less than one quarter (22.6% of their first child) had received two doses, and 19.0% had received one dose of the vaccine against COVID-19 (Table 1).
Table 1. Demographic characteristics of participants and COVID-19 vaccination (n = 399).
| Demographic Variables | Value or Category | Frequency (Percent %) |
| Informant: | Mother | 327 (82.0%) |
| Father | 72 (18.0%) | |
| Age: | 20-30 years | 108 (27.1%) |
| 31-40 years | 158 (39.6%) | |
| 41-50 years | 102 (25.6%) | |
| 51-60 years | 31 (7.8%) | |
| Education level: | Intermediate school | 14 (3.5%) |
| High school | 56 (14.0%) | |
| Bachelor's degree | 230 (57.6%) | |
| Diploma | 48 (12.0%) | |
| Postgraduate | 51 (12.8%) | |
| Employment status: | Employed | 210 (52.6%) |
| Retired | 30 (7.5%) | |
| Unemployed | 159 (39.8%) | |
| Working field: | Security field | 11 (2.8%) |
| Health field | 62 (15.5%) | |
| Education field | 88 (22.1%) | |
| Engineering field | 11 (2.8%) | |
| Business field | 27 (6.8%) | |
| Craftsmanship | 3 (0.8%) | |
| Freelance work | 17 (4.3%) | |
| Other | 11 (2.8%) | |
| Not working at all | 169 (42.4%) | |
| Marital status: | Married | 375 (94.0%) |
| Single | 24 (6.0%) | |
| Family monthly income: | More than 15000 SAR | 193 (48.4%) |
| Less than 15000 SAR | 206 (51.6%) | |
| Number of children: | One | 58 (14.6%) |
| Two | 87 (21.8%) | |
| Three | 90 (22.6%) | |
| More than three | 164 (41.1%) | |
| Do any of your children (ages 5-21) suffer from any chronic diseases? | No | 334 (83.7%) |
| Yes, diabetes | 25 (6.3%) | |
| Yes, asthma | 26 (6.5%) | |
| Yes, sickle cell anemia | 22 (5.5%) | |
| Yes, leukemia | 8 (2.0%) | |
| Yes, Others | 12 (3.0%) | |
| Did all children (ages 5-12) receive the vaccine against COVID-19? | Yes | 195 (48.9%) |
| No | 204 (51.1%) | |
| Number of first-child doses of the vaccine against COVID-19 (if you answered the previous this question with yes) you: | Not applicable | 204 (51.1%) |
| One dose | 76 (19.0%) | |
| Two doses | 90 (22.6%) | |
| Three doses | 27 (6.8%) | |
| Four doses | 2 (0.5%) |
Regarding the side effects of the COVID-19 vaccine, less than half of respondents (48%) reported that their children had side effects. Also, more than one-third (35.1%) reported that the symptoms appeared after the first day of the vaccine, and one-quarter (25%) mentioned that the symptoms persisted for one to three days. The most common side effects experienced by the first and second children were pain at the injection site (first child: 66.70%, second child: 66.20%), fever (first child: 43.10%, second child: 47.50%), swelling at the injection site (first child: 33.30%, second child: 38.10%), and headache (first child: 31.30%, second child: 28.10%). (Table 2, Figure 1).
Table 2. Side effects of COVID-19 vaccine.
| Side effects of COVID-19 vaccine | Value or Category | Frequency (Percent) |
| Are the side effects that appeared on your children similar to each other? | Yes | 71 (17.8%) |
| No | 123 (30.8%) | |
| Don’t have side effect | 205 (51.4%) | |
| When did the symptoms of your child/children begin after taking the vaccine? | After the first day | 140 (35.1%) |
| After the second day | 42 (10.5%) | |
| After more than 3 days | 13 (3.3%) | |
| Symptoms not appeared | 204 (51.1%) | |
| What is the average duration of side effects for your child? | 1-3 days | 101 (25.3%) |
| 3-5 days | 50 (12.5%) | |
| 5-7 days | 32 (8.0%) | |
| One week – 4 weeks | 9 (2.3%) | |
| More than 1 month | 3 (0.8%) | |
| Symptoms not appeared | 204 (51.1%) |
Figure 1. Side effects of COVID-19 vaccine.
Regarding the attitude about COVID-19, 42% of respondents thought it was extremely likely that COVID-19 is a serious disease; 45% believed it was somewhat likely that they and their children are susceptible to COVID-19, and one quarter expressed their agreement with the safety of the COVID-19 vaccine. In addition, 26% strongly agreed that getting vaccinated helps prevent severe illnesses from COVID-19. Moreover, there were many concerns during the pandemic: 71% of the respondents feared that a family member would contract the virus, 57% worried that they would become infected, and 42% expressed concern over the possibility of death (Table 3).
Table 3. Attitude towards COVID-19 and its vaccination (=399).
| What do you think about COVID-19? | Value of category | Frequency (Percent) |
| I think COVID-19 is a serious disease. | Extremely likely | 171 (42.9%) |
| Somewhat likely | 115 (28.8%) | |
| Somewhat unlikely | 40 (10.0%) | |
| Extremely unlikely | 29 (7.3%) | |
| It depends on who gets COVID-19 | 44 (11.0%) | |
| I think that my child/ren and I are vulnerable to COVID-19. | Extremely likely | 143 (35.8%) |
| Somewhat likely | 180 (45.1%) | |
| Somewhat unlikely | 47 (11.8%) | |
| Extremely unlikely | 29 (7.3%) | |
| Do you think you have enough information about COVID-19 vaccines? | Extremely likely | 200 (50.1%) |
| Somewhat likely | 117 (29.3%) | |
| Somewhat unlikely | 56 (14.0%) | |
| Extremely unlikely | 26 (6.5%) | |
| How likely would you think the information about COVID-19 vaccines are reliable? | Extremely likely | 140 (35.1%) |
| Somewhat likely | 170 (42.6%) | |
| Somewhat unlikely | 56 (14.0%) | |
| Extremely unlikely | 33 (8.3%) | |
| In general, about COVID-19 vaccination vaccines are safe. | Strongly agree | 96 (24.1%) |
| Agree | 100 (25.1%) | |
| Neutral | 128 (32.1%) | |
| Disagree | 47 (11.8%) | |
| Strongly disagree | 28 (7.0%) | |
| Vaccination against COVID-19 can help to prevent serious illnesses that occurs due to the COVID-19 | Strongly agree | 104 (26.1%) |
| Agree | 115 (28.8%) | |
| Neutral | 107 (26.8%) | |
| Disagree | 51 (12.8%) | |
| Strongly disagree | 22 (5.5%) | |
| COVID-19 vaccine could have common side effect like any other vaccine | Strongly agree | 163 (40.9%) |
| Agree | 154 (38.6%) | |
| Neutral | 51 (12.8%) | |
| Disagree | 21 (5.3%) | |
| Strongly disagree | 10 (2.5%) | |
| If you have side effect from COVID-19 vaccine probably will disappear after a few day | Strongly agree | 108 (27.1%) |
| Agree | 156 (39.1%) | |
| Neutral | 78 (19.5%) | |
| Disagree | 38 (9.5%) | |
| Strongly disagree | 19 (4.8%) | |
| My concerns about related side effects prevent me from taking a vaccine for the prevention of COVID-19. | Strongly agree | 106 (26.6%) |
| Agree | 99 (24.8%) | |
| Neutral | 92 (23.1%) | |
| Disagree | 77 (19.3%) | |
| Strongly disagree | 25 (6.3%) | |
| Have you or someone you know ever had a bad reaction to a vaccine? | Yes | 186 (46.6%) |
| No | 136 (34.1%) | |
| Not sure | 77 (19.3%) | |
| What are you most worried about during this COVID-19 pandemic? | Fear of becoming infected myself | 230 (57.6%) |
| Fear of a family member becoming infected | 287 (71.9%) | |
| Death | 169 (42.4%) | |
| Financial related worries | 58 (14.5%) | |
| Job-related worries | 51 (12.8%) | |
| Food insecurity related worries | 56 (14.0%) | |
| Unavailability of vaccines | 86 (21.6%) | |
| Being a plot or conspiracy | 88 (22.1%) | |
| Being forced to take a medication | 57 (14.3%) | |
| Being forced to take a vaccine | 105 (26.3%) | |
| I am not worried about any issues | 42 (10.5%) |
Regarding the acceptance and hesitancy of the COVID-19 vaccine, more than one-third of the participants (35%) were hesitant about the vaccination due to fearing side effects, thinking the vaccine might not be effective (15.8%), having read dangerous information about the vaccine (12%), or thinking the vaccine might interact with other diseases (11%). However, 40% of their children had received a vaccine against COVID-19 because it was mandatory, and 15% because they believed the vaccine would protect their children against COVID-19 (Table 4).
Table 4. Causes of acceptance and hesitancy of COVID-19 vaccine (n=399).
| Causes of acceptance and refusal of vaccine against COVID-19 | Value of category | Frequency (Percent ) |
| What are your concerns about getting your child vaccinated against COVID-19? | Fear about adverse effects of vaccination | 142 (35.6%) |
| Children have good immunity as they don't need vaccination | 3 (0.8%) | |
| The vaccines might not be effective | 63 (15.8%) | |
| Death of one of the family members | 25 (6.3%) | |
| have read dangerous information about the vaccine | 49 (12.3%) | |
| Not enough studies on the vaccine and its side effects | 3 (0.8%) | |
| The vaccine may interact with other diseases | 46 (11.5%) | |
| No concerns | 68 (17.0%) | |
| If your children receive a vaccine against COVID-19, choose the reason for acceptance | Because it is a mandatory | 160 (40.1%) |
| Protect my children against COVID-19 | 60 (15.0%) | |
| Help to end the pandemic | 17 (4.3%) | |
| Reduce the severity of symptoms during the disease | 36 (9.0%) |
Regarding the sources of information about the COVID-19 vaccine around one-third of participants (32.6%) mentioned healthcare providers (such as physicians and pharmacists, etc.) as a trusted source for information about vaccines, followed by the government (17.0%) and the internet (11.3%). Social media and pharmaceutical company reports were trusted by 8.5% and 3.3%, respectively, while 10.0% reported not trusting any source (Figure 2).
Figure 2. Sources of information regarding COVID-19 vaccine (n=399).
The demographic features of the participants (working field and income) had a statistically significant link with vaccine acceptability, according to the Chi-square test (p-value= 0.011). However, several other factors were not found to be associated. Furthermore according to the Chi-square statistic, fear of side effects, the belief that the vaccine might not be effective, and having read dangerous information about the vaccine were all significantly associated with hesitance to receive the COVID-19 vaccine at the 0.05 level. (Tables 5, 6).
Table 5. Association of demographic characteristics and status of vaccination (n=399).
* The Chi-square statistic is significant at the 0.05 level.
| Variables | Did all children (ages 5-12) receive the vaccine against COVID-19? | Chi-square | p-value | ||
| Yes | No | ||||
| Informant | Mother | 48.6% | 51.4% | 0.045 | 0.833 |
| Father | 50.0% | 50.0% | |||
| Age | 20-30 years | 43.5% | 56.5% | 3.952 | 0.267 |
| 31-40 years | 47.5% | 52.5% | |||
| 41-50 years | 52.9% | 47.1% | |||
| 51-60 years | 61.3% | 38.7% | |||
| Education | Intermediate school | 64.3% | 35.7% | 3.760 | 0.439 |
| high school | 42.9% | 57.1% | |||
| Bachelor's degree | 47.0% | 53.0% | |||
| Diploma | 54.2% | 45.8% | |||
| Postgraduate | 54.9% | 45.1% | |||
| Employment status | Employed | 51.0% | 49.0% | 2.225 | 0.329 |
| Retired | 56.7% | 43.3% | |||
| Unemployed | 44.7% | 55.3% | |||
| Working field | Security field | 81.8% | 18.2% | 16.185 | 0.040* |
| Health field | 45.2% | 54.8% | |||
| Education field | 55.7% | 44.3% | |||
| Engineering field | 72.7% | 27.3% | |||
| Business field | 51.9% | 48.1% | |||
| Craftsmanship | 100.0% | 0.0% | |||
| Freelance work | 35.3% | 64.7% | |||
| Other | 36.4% | 63.6% | |||
| Not working at all | 43.8% | 56.2% | |||
| Marital status | Married | 47.7% | 52.3% | 3.236 | 0.072 |
| Single | 66.7% | 33.3% | |||
| Family monthly income | More than 15000 | 59.6% | 40.4% | 17.171 | < 0.001* |
| Less than 15000 | 38.8% | 61.2% | |||
| Chronic disease | No | 48.5% | 51.5% | .112 | 0.738 |
| Yes | 50.8% | 49.2% | |||
| Number of children | Less than 5 | 46.9% | 53.1% | 1.664 | 0.197 |
| 5 and above | 54.2% | 45.8% | |||
Table 6. Association between concerns about getting COVID-19 vaccine and status of vaccination (n=399).
* The Chi-square statistic is significant at the 0.05 level
| What are your concerns about getting your child vaccinated against COVID-19? | Did all children (ages 5-12) receive the vaccine against COVID-19? | Chi-square | p-value | |
| Yes | No | |||
| Column % | Column % | |||
| No mention of any concern | 23.6% | 10.8% | 18.16 | 0.011* |
| Fear about adverse effects of vaccination | 30.3% | 40.7% | ||
| Children have good immunity as they don't need vaccination | 1.0% | 0.5% | ||
| The vaccines might not be effective | 11.8% | 19.6% | ||
| The vaccines may cause some health problems in the future | 0.0% | 0.0% | ||
| Death of one of the family members | 6.2% | 6.4% | ||
| I have read dangerous information about the vaccine | 13.3% | 11.3% | ||
| There are not enough studies on the vaccine and its side effects | 1.0% | 0.5% | ||
| The vaccine may interact with other diseases | 12.8% | 10.3% | ||
Discussion
This study aims to identify Saudi parents' hesitancy and behaviors regarding COVID-19 vaccinations of their children aged five to 12 years old and to investigate the causes of acceptance and hesitancy that may encourage or prevent Saudi parents from vaccinating their children against the COVID-19 virus. The COVID-19 immunization in Saudi Arabia was expanded to children over the age of 12 in June 2021 and to children aged five to 11 in January 2022 [17].
We found that about half of the participants (48.9%), their children, aged five to 12, had received the vaccine against COVID-19. These findings were slightly higher than the findings reported in Jordan (30%) [18], Turkey (36.3%) [19], Iraq (38%) [20], Saudi Arabia (44%) [12] and England (48.2%) [7]. Our findings were less than previous studies in the United States (63%) [21], Canada (63%)[22], Japan (64.7%) [23], Egypt (65.6%) [24], Italy (68.5%)[25], China (72.6%) [8], Malaysia (73.6%) [26] and UAE (75.1%) [27].
This study demonstrates the actual percentage of children who have been vaccinated, in contrast to prior studies, which have only shown parents' intentions to vaccinate their children.
The primary concerns of parents in the current study about vaccinating their children were the possible adverse effects of the vaccine (35%), thinking the vaccine might not be effective (15.8%), having read dangerous information about the vaccine (12%), or thinking the vaccine might interact with other diseases (11%). These findings are consistent with earlier research in Egypt, where the primary worries were the vaccine's adverse effects (68.3%) and ideas of conspiracies (18%) [24], and in Malaysia, where the common reasons against vaccination were uncertainty regarding the new vaccine (96.1%), concerns regarding vaccine ingredients (93.2%), shortage of vaccine information provided from clinicians (82.3%), and the notion that vaccines are unsafe (79.8%) [25]. Several previous studies have found that parents are hesitant to vaccinate their children because of worries regarding adverse side effects: 42.9% in Saudi Arabia [14], 46.8% in Romania [28], 61.5% in Boston [29], 76.9% in Turkey [19] and 84.1% in Korea [16].
The current study revealed that the primary factors that prompted parents to give their children the COVID-19 vaccine were that it was mandatory (40%), and to protect their children against COVID-19 (15%). Moreover, working field and high income had a statistically significant correlation with vaccine acceptance. Previous studies in Malaysia showed that the reasons for willingly immunizing children were for their protection (99.4%), protection of their family members (99.3%), and effectiveness (98.2%) [26]. Protecting the child’s health was the main reason for parent’s acceptance among previous studies in Saudi Arabia (24.1%) [14], UAE (55.5%) [27] and Turkey (75.5%) [19].
According to the current study, approximately one-third of the respondents (32.6%) cited healthcare providers as a reliable source of vaccine information, followed by the government (17.0%), the internet (11.3%), and social media (8.5%). These findings are consistent with previous studies in the United States, where 64.88% of respondents relied on healthcare providers for information about the vaccine, while 15% reported relying on social media [30]. In contrast, a previous study in Palestine reported that social media, the internet, and healthcare professionals were the main sources of information about the COVID-19 vaccine (22.07%, 18.74%, and 11.92%, respectively) [31]. These variations in information sources highlight the importance of understanding the local context when developing communication strategies and policies to encourage vaccine uptake.
The current study reports that 42% of respondents thought it was extremely likely that COVID-19 is a serious disease, 45% believed it was somewhat likely that they and their children are susceptible to COVID-19, and one quarter expressed their agreement with the safety of the COVID-19 vaccine. In addition, 26% strongly agreed that getting vaccinated helps prevent severe illnesses from COVID-19. Moreover, there were many concerns during the pandemic, where 71% of the respondents feared that a family member would contract the virus, 57% worried that they would become infected, and 42% expressed concern over the possibility of death. These findings are similar to findings in previous studies in Najran, Saudi Arabia, in which nearly 70% of parents agreed that the COVID-19 vaccine was effective [32] and in Italy, where 78.7% agreed that COVID-19 is a serious disease and 42.3% agreed that it is preventable [25].
Regarding the side effects of the COVID-19 vaccine, less than half of those who responded (48%) reported that their children had side effects. More than one-third (35.1%) reported that the symptoms appeared after the first day of the vaccine, and one-quarter (25%) mentioned that the symptoms persisted for one to three days. The most frequent adverse effects experienced by the first and second children were pain at the injection site (first child: 66.70%, second child: 66.20%), fever (first child: 43.10%, second child: 47.50%), swelling at the injection site (first child: 33.30%, second child: 38.10%), and headache (first child: 31.30%, second child: 28.10%). These findings are consistent with previous studies at the national level, which reported that 50.4% of children experienced side effects. The majority of them (78.9%) said that adverse effects began one day after receiving the immunization, and 65.7% reported that they lasted one to three days. In addition, the most documented effect was pain at the injection site (15.3%) [33]. The World Health Organization (WHO) stated that COVID-19 vaccines, like other vaccines, could cause adverse effects. However, most of these adverse effects were minor and of short duration [34].
Limitations of the study
Our study demonstrated some limitations. One of them is that as there is no central immunization record in Saudi Arabia for the COVID-19 vaccine and the parents reported the child’s vaccination status, this could potentially be underestimated or overstated due to social desirability or recollection bias. In addition, instead of a direct face-to-face interview, study results were recorded via a web-based, self-administered survey. This may result in prejudice in reporting their responses.
Conclusions
The rate of children (ages five to 12) who received the COVID-19 vaccine was acceptable in the current study. Although the study found that the main concern of parents about vaccinating their children was the possible side effects of the vaccine, the side effects were reported in less than half of the vaccinated children. The most common side effects experienced were pain at the injection site, fever, swelling at the injection site, and headache that appeared after the first day of the vaccine and lasted for a few days. Public health authorities and other organizations should provide reliable and easy-to-understand information through a variety of media, including social media platforms, to influence population attitudes towards vaccination and emerging health problems.
Appendices
Appendix 1
Parent's willingness and attitude concerning COVID-19 vaccine and its side effects in Saudi Arabia, Eastern region questionnaire.
Table 7. Participant consent.
| Do you agree to participate in the questionnaire for the research? | Yes |
| No |
Part 1
Parents information
Table 8. Parents information.
| Question | Options |
| Gender: | Female ( the mother ) |
| Male ( the father ) | |
| Age: | 20-30 |
| 31-40 | |
| 41-50 | |
| 51-60 | |
| Education (Degree): | Intermediate school |
| High school | |
| Bachelor's degree | |
| Diploma | |
| Postgraduate | |
| Employment status: | Employed |
| Unemployed | |
| Retired | |
| Working field: | Security field |
| Health field | |
| Education field | |
| Engineering field | |
| Business field | |
| Freelance work | |
| Other | |
| Marital status: | Married |
| Single | |
| Family monthly income: | More than 15000 |
| Less than 15000 | |
| Number of children: | Short answer |
Part 2
Child information
Table 9. Child information.
| Question | Options |
| Age of 1st child: | 5 year |
| 6 years | |
| 7 years | |
| 8 years | |
| 9 years | |
| 10 years | |
| 11 years | |
| 12 years | |
| Age of the 2nd child: | 5 year |
| 6 years | |
| 7 years | |
| 8 years | |
| 9 years | |
| 10 years | |
| 11 years | |
| 12 years | |
| Do any of your children (ages 5-21) suffer from any chronic diseases? | No |
| Yes, diabetes | |
| Yes, asthma | |
| Yes, sickle cell anemia | |
| Yes, leukemia | |
| Did all children (ages 5-12) receive the vaccine against COVID-19? | Yes |
| No | |
| Note: if the participant answer this question with NO will skip the 3rd part and move to 4th part | |
| Number of first-child doses of the vaccine against COVID-19 (if you answered the previous question with yes ) you: | One dose |
| Two doses | |
| Three doses | |
| Four doses | |
| Number of second child doses of the vaccine against COVID-19 (if you answered the previous question with yes) | One dose |
| Two doses | |
| Three doses | |
| Four doses | |
Part 3
Side effects of COVID-19 vaccine
Table 10. Side effects of COVID-19 vaccine.
| Question | Options |
| Are the side effects that appeared on your children similar to each other? | Yes |
| No | |
| What are the effects of the effects that your first child suffered after taking the vaccine? (you can choose more than one answer): | Pain at the injection site |
| Swelling at the injection site | |
| Redness at the injection site | |
| Fever | |
| Headache | |
| Nausea | |
| Vomiting | |
| Tightness in the chest | |
| Pain in the joints | |
| Muscle pain | |
| Discomfort and malaise | |
| Lymph node swelling | |
| Rash | |
| Hives with new itching | |
| A skin rash with raised red and white spots above the surface of the skin | |
| Infections in the corners of the lips | |
| Mouth ulcers | |
| Numbness of the mouth | |
| A change in the sense of taste | |
| dry mouth | |
| Change in mouth odor | |
| Bleeding gums | |
| Swellings in the sides of the inner mouth | |
| What are the effects of the effects that your first child suffered after taking the vaccine? (you can choose more than one answer): | Pain at the injection site |
| Swelling at the injection site | |
| Redness at the injection site | |
| Fever | |
| Headache | |
| Nausea | |
| Vomiting | |
| Tightness in the chest | |
| Pain in the joints | |
| Muscle pain | |
| Discomfort and malaise | |
| Lymph node swelling | |
| Rash | |
| Hives with new itching | |
| A skin rash with raised red and white spots above the surface of the skin | |
| Infections in the corners of the lips | |
| Mouth ulcers | |
| Numbness of the mouth | |
| A change in the sense of taste | |
| dry mouth | |
| Change in mouth odor | |
| Bleeding gums | |
| Swellings in the sides of the inner mouth | |
| When did the symptoms of your child/children begin after taking the vaccine? | After the first day |
| After the second day | |
| After more than 3 days | |
| What is the average duration of side effects for you child? | 1-3 days |
| 3-5 days | |
| 5-7 days | |
| One week – 4 weeks | |
| More than 1 month |
Part 4
What do you think about COVID-19?
Table 11. What do you think about COVID-19?
| Question | Options |
| I think COVID-19 is a serious disease. | Extremely likely |
| Somewhat likely | |
| Somewhat unlikely | |
| Extremely unlikely | |
| It depends on who gets COVID-19 | |
| I think that I and my child(ren) are vulnerable to COVID-19. | Extremely likely |
| Somewhat likely | |
| Somewhat unlikely | |
| Extremely unlikely | |
| Do you think you have enough information about COVID-19 vaccines? | Extremely likely |
| Somewhat likely | |
| Somewhat unlikely | |
| Extremely unlikely | |
| How likely would you think the information about COVID-19 vaccines are reliable? | Extremely likely |
| Somewhat likely | |
| Somewhat unlikely | |
| Extremely unlikely | |
| In general, about COVID-19 vaccination vaccines are safe. | Strongly agree |
| Agree | |
| Neutral | |
| Disagree | |
| Strongly disagree | |
| Vaccination against COVID-19 can help to prevent serious illnesses that occurs due to the COVID-19 | Strongly agree |
| Agree | |
| Neutral | |
| Disagree | |
| strongly disagree | |
| COVID-19 vaccine could have common side effect like any other vaccine | Strongly agree |
| Agree | |
| Neutral | |
| Disagree | |
| Strongly disagree | |
| If you have side effects from the COVID-19 vaccine probably it will disappear after a few day | Strongly agree |
| Agree | |
| Neutral | |
| Disagree | |
| Strongly disagree |
Part 5
What do you think about COVID-19 vaccination?
Table 12. What do you think about COVID-19 vaccination.
| Question | Options |
| Have you or someone you know ever had a bad reaction to a vaccine? | Yes |
| No | |
| Not sure | |
| What are you most worried about during this COVID-19 pandemic? (Tick not more than 5) | Fear of becoming infected myself |
| Fear of a family member becoming infected | |
| Death | |
| Financial related worries | |
| Job-related worries | |
| Food insecurity related worries | |
| Unavailability of vaccines | |
| Being a plot or conspiracy | |
| Being forced to take a medication | |
| Being forced to take a vaccine | |
| I am not worried about any issues | |
| Other | |
| Who do you trust the most for information about vaccines? | Media (TV, Radio, Newspaper) |
| Internet | |
| Social media (Facebook, Twitter, WhatsApp, ..etc.) | |
| Health care providers: Physicians, pharmacists, etc. | |
| Family-members | |
| Government (JFDA) | |
| The pharmaceutical company reports | |
| Scientific articles | |
| I do not trust any source |
Part 6
Causes of acceptance and refusal of vaccination against COVID-19
Table 13. Causes of acceptance and refusal of vaccination against COVID-19.
| Question | Options |
| My concerns about related side effects will prevent me from taking a vaccine for the prevention of COVID-19. | Strongly agree |
| Agree | |
| Neutral | |
| Disagree | |
| Strongly disagree | |
| What are your concerns about getting your child vaccinated against COVID-19? (you can choose more than one option) | Adverse events after vaccination |
| The vaccines have not been sufficiently | |
| The vaccines might not be effective enough | |
| Death of one of the family members | |
| Others | |
| The vaccines may cause some health problems in the future | |
| If your children receive a vaccine against COVID-19, choose the reason for acceptance | Because it is a mandatory |
| Protect my children against COVID-19, | |
| Help to end the pandemic | |
| Reduce the severity of symptoms during the disease |
The authors have declared that no competing interests exist.
Author Contributions
Concept and design: Omalbneen H. Alrofaie, Sarah K. Alateeq, Fidaa R. Bin obaid
Acquisition, analysis, or interpretation of data: Omalbneen H. Alrofaie, Rabab A. Majzoub, Lena K. Almotreb, Sarah K. Alateeq, Fidaa R. Bin obaid
Drafting of the manuscript: Omalbneen H. Alrofaie, Lena K. Almotreb, Sarah K. Alateeq, Fidaa R. Bin obaid
Critical review of the manuscript for important intellectual content: Rabab A. Majzoub
Supervision: Rabab A. Majzoub
Human Ethics
Consent was obtained or waived by all participants in this study. The Research Ethics Committee at King Faisal University issued approval KFU-REC-2022-NOV-ETHICS301. Having reviewed the details submitted by the applicant regarding the abovenamed research project, the Research Ethics Committee at King Faisal University grants its ethical approval to the protocol. Projects may be subject to an audit or any other form of monitoring by the committee at any time. The committee may request a regular report on the progress of the project to ensure that researchers are committed to the highest ethical standards. Researchers are held accountable for the storage, retention and security of original data obtained from projects. Any substantial alterations to the project or emerging events or matters that may affect the ethical acceptability of the project must be reported immediately to the committee via email (.sa) or phone (0096615899773).
Animal Ethics
Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.
References
- 1.Clinical characteristics of coronavirus disease 2019 in China. Guan WJ, Ni ZY, Hu Y, et al. https://www.nejm.org/doi/full/10.1056/neJMoa2002032. N Engl J Med. 2020;382:1708–1720. doi: 10.1056/NEJMoa2002032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Safety, immunogenicity, and efficacy of the BNT162b2 covid-19 vaccine in adolescents. Frenck RW Jr, Klein NP, Kitchin N, et al. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174030/ N Engl J Med. 2021:0. doi: 10.1056/NEJMoa2107456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age. Walter EB, Talaat KR, Sabharwal C, et al. https://www.nejm.org/doi/full/10.1056/NEJMoa2116298. N Engl J Med. 2022;386:35–46. doi: 10.1056/NEJMoa2116298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.The Advisory Committee on Immunization Practices’ Interim Recommendation for use of Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12-15 Years — United States, May 2021. Wallace M, Woodworth KR, Gargano JW, et al. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136423/ MMWR Morb Mortal Wkly Rep. 2021;70:749–752. doi: 10.15585/mmwr.mm7020e1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. Polack FP, Thomas SJ, Kitchin N, et al. https://archivos.evidenciasenpediatria.es/_1wdMqnwxv5io8MsQyAC1eQvxMejv2aVG7mMuiIpw3kzoP63nMnjoL33zDz86pyxf80GmQbU_08Y. N Engl J Med. 2020;383:2603–2615. doi: 10.1056/NEJMoa2034577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Comirnaty and Pfizer-BioNTech COVID-19 vaccine. [ Apr; 2022 ]. 2022. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/comirnaty-and-pfizer-biontech-covid-19-vaccine https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/comirnaty-and-pfizer-biontech-covid-19-vaccine
- 7.Parents' and guardians' views on the acceptability of a future COVID-19 vaccine: a multi-methods study in England. Bell S, Clarke R, Mounier-Jack S, Walker JL, Paterson P. https://www.sciencedirect.com/science/article/pii/S0264410X20313219. Vaccine. 2020;38:7789–7798. doi: 10.1016/j.vaccine.2020.10.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Parental acceptability of COVID-19 vaccination for children under the age of 18 years: cross-sectional online survey. Zhang KC, Fang Y, Cao H, et al. https://pediatrics.jmir.org/2020/2/e24827/ JMIR Pediatr Parent. 2020;3:0. doi: 10.2196/24827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Side effects of COVID-19 Pfizer-BioNTech mRNA vaccine in children aged 12-18 years in Saudi Arabia. Alamer E, Alhazmi A, Qasir NA, et al. https://www.mdpi.com/2076-393X/9/11/1297. Vaccines (Basel) 2021;9 doi: 10.3390/vaccines9111297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Vaccine hesitancy towards childhood immunizations as a predictor of mothers’ intention to vaccinate their children against COVID-19 in Saudi Arabia. [ Sep; 2023 ];Aldakhil H, Albedah N, Alturaiki N, Alajlan R, Abusalih H. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390407/ J Infect Public Health. 2021 14:1497–1504. doi: 10.1016/j.jiph.2021.08.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Vaccine hesitancy among Saudi parents and its determinants: result from the WHO SAGE working group on vaccine hesitancy survey tool. Alsubaie SS, Gosadi IM, Alsaadi BM, et al. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969619/ Saudi Med J. 2019;40:1242–1250. doi: 10.15537/smj.2019.12.24653. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Parents' willingness to vaccinate children against COVID-19 in Saudi Arabia: a cross-sectional study. Ennaceur S, Al-Mohaithef M. https://www.mdpi.com/2076-393X/10/2/156. Vaccines (Basel) 2022;10 doi: 10.3390/vaccines10020156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Children's rates of COVID-19 vaccination as reported by parents, vaccine hesitancy, and determinants of COVID-19 vaccine uptake among children: a multi-country study from the Eastern Mediterranean Region. Khatatbeh M, Albalas S, Khatatbeh H, et al. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-022-13798-2. BMC Public Health. 2022;22:1375. doi: 10.1186/s12889-022-13798-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Caregivers’ willingness to vaccinate their children against COVID-19 in Saudi Arabia: a cross-sectional survey. Almusbah Z, Alhajji Z, Alshayeb Z, et al. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445852/ Cureus. 2021;13:0. doi: 10.7759/cureus.17243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.GASTAT. [ Aug; 2023 ]. 2023. https://database.stats.gov.sa/home/indicator/535 https://database.stats.gov.sa/home/indicator/535
- 16.Pediatric and parents' attitudes towards covid-19 vaccines and intention to vaccinate for children. Choi SH, Jo YH, Jo KJ, Park SE. https://synapse.koreamed.org/articles/1147344. J Korean Med Sci. 2021;36:0. doi: 10.3346/jkms.2021.36.e227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.First dose of COVID-19 vaccine is available for children aged 5-11 Years. [ Jul; 2023 ]. 2022. https://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/News-2022-01-16-002.aspx https://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/News-2022-01-16-002.aspx
- 18.Parents' attitudes, knowledge and practice towards vaccinating their children against COVID-19: a cross-sectional study. Al-Qerem W, Al Bawab AQ, Hammad A, et al. https://www.tandfonline.com/doi/full/10.1080/21645515.2022.2044257. Hum Vaccin Immunother. 2022;18:2044257. doi: 10.1080/21645515.2022.2044257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Parents' willingness and attitudes concerning the COVID-19 vaccine: a cross-sectional study. Yılmaz M, Sahin MK. https://onlinelibrary.wiley.com/doi/full/10.1111/ijcp.14364. Int J Clin Pract. 2021;75:0. doi: 10.1111/ijcp.14364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Iraqi parents' knowledge, attitudes, and practices towards vaccinating their children: a cross-sectional study. Al-Qerem W, Jarab A, Hammad A, et al. https://www.mdpi.com/2076-393X/10/5/820. Vaccines (Basel) 2022;10 doi: 10.3390/vaccines10050820. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Parents’ likelihood to vaccinate their children and themselves against COVID-19. Davis MM, Zickafoose JS, Halvorson AE, Patrick SW. https://www.medrxiv.org/content/10.1101/2020.11.10.20228759v1 MedRxiv. 2020;11 [Google Scholar]
- 22.Canadian parents' perceptions of COVID-19 vaccination and intention to vaccinate their children: results from a cross-sectional national survey. Humble RM, Sell H, Dubé E, et al. https://www.sciencedirect.com/science/article/pii/S0264410X21013098. Vaccine. 2021;39:7669–7676. doi: 10.1016/j.vaccine.2021.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Factors of parental COVID-19 vaccine hesitancy: a cross sectional study in Japan. Horiuchi S, Sakamoto H, Abe SK, et al. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0261121. PLoS One. 2021;16:0. doi: 10.1371/journal.pone.0261121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Parents’ intentions and associated factors to vaccinating their children aged 12-17 years with COVID-19 vaccines: a cross sectional study. Al-Wutayd O, Al-Batanony M, Badr N, Abdelwanees S. https://www.mdpi.com/2076-393X/10/6/912. Vaccines (Basel) 2022;10 doi: 10.3390/vaccines10060912. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Parents’ willingness to vaccinate their children with COVID-19 vaccine: results of a survey in Italy. Di Giuseppe G, Pelullo CP, Volgare AS, Napolitano F, Pavia M. https://www.sciencedirect.com/science/article/pii/S1054139X22000258. J Adolesc Health. 2022;70:550–558. doi: 10.1016/j.jadohealth.2022.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.The willingness of parents to vaccinate their children younger than 12 years against COVID-19: a cross-sectional study in Malaysia. Ng DL, Gan GG, Chai CS, et al. https://link.springer.com/article/10.1186/s12889-022-13682-z. BMC Public Health. 2022;22:1265. doi: 10.1186/s12889-022-13682-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Parents' views on the acceptability of a COVID-19 vaccine for their children: a cross-sectional study in Abu Dhabi-United Arab Emirates. AlKetbi LM, Al Hosani F, Al Memari S, et al. https://www.sciencedirect.com/science/article/pii/S0264410X22009549. Vaccine. 2022;40:5562–5568. doi: 10.1016/j.vaccine.2022.07.056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Factors that can influence in Romania the parents’ decision regarding the anti COVID-19 vaccination of children and adolescents aged 12-15. Sandu P, Rajka D, Pintea A, Moldovan K, Pintea S, Pop TL. https://www.revista-medicina-scolara.ro/print_article.php?did=13116 J Sch Univ Med. 2021;8:19–29. [Google Scholar]
- 29.Parents' intentions to vaccinate their children against COVID-19. Ruggiero KM, Wong J, Sweeney CF, Avola A, Auger A, Macaluso M, Reidy P. https://www.sciencedirect.com/science/article/pii/S0891524521000808. J Pediatr Health Care. 2021;35:509–517. doi: 10.1016/j.pedhc.2021.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Trusted sources of COVID-19 vaccine information among hesitant adopters in the United States. Purvis RS, Hallgren E, Moore RA, Willis DE, Hall S, Gurel-Headley M, McElfish PA. https://www.mdpi.com/2076-393X/9/12/1418. Vaccines (Basel) 2021;9 doi: 10.3390/vaccines9121418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Public knowledge, attitude, and acceptance toward COVID-19 vaccines in Palestine: a cross-sectional study. Al-Kafarna M, Matar SG, Almadhoon HW, et al. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-022-12932-4. BMC Public Health. 2022;22:529. doi: 10.1186/s12889-022-12932-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Parents' attitudes, their acceptance of the covid-19 vaccines for children and the contributing factors in Najran, Saudi Arabia: a cross-sectional survey. Aedh AI. https://www.mdpi.com/2076-393X/10/8/1264. Vaccines (Basel) 2022;10 doi: 10.3390/vaccines10081264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia. Alwafi H, Naser AY, Aldhahir AM, et al. https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-022-07905-2. BMC Infect Dis. 2022;22:911. doi: 10.1186/s12879-022-07905-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Vaccines and immunization: vaccine safety. [ Jul; 2023 ]. 2020. https://www.who.int/news-room/questions-and-answers/item/vaccines-and-immunization-vaccine-safety https://www.who.int/news-room/questions-and-answers/item/vaccines-and-immunization-vaccine-safety


